Savvy Trades and Investments

[hweb2]

Anyone still follow CCEL? Might be one for the watchlist. This stem cell company is nicely profitable, but not a real low P/E (as you'd expect given the sector). In July they reported fiscal Q2 earnings of .12/share vs. .01/share last year. But a couple of things caught my eye on this one. First they're acquiring these patents from Duke:

https://www.marketwatch.com/press-release/cord-blood-banking-leader-cryo-cell-enters-into-patent-option-agreement-with-duke-university-2020-06-11?siteid=bigcharts&dist=bigcharts&tesla=y

They seemed pretty excited about the news...here's a quote from that PR:

David Portnoy, Chairman of the Board and Co-CEO, said, "Cryo-Cell is honored to have entered into this option agreement with Dr. Kurtzberg and Duke University and believes that this is a significant step in the transformation of the Company. We look forward to Duke becoming a major shareholder and partner of the Company for many years to come."

So Duke is going to become a major shareholder of CCEL!?! That seems like pretty awesome news. Imagine if this stock was listed. Would probably double or triple in a day on the Duke news.

Maybe there's a listing in the works. Which brings me to the second item of interest. The co-CEO's have been buying a bunch of stock in recent weeks. Not sure if it's the Duke news or something else. But whatever it is, something exciting seems to be going on.

From the earnings PR last month:

On June 9, 2020, Cryo-Cell entered into a patent option agreement with Duke University. The six-month exclusive option agreement gives Cryo-Cell an option to obtain a license to manufacture and sell products/services based on Duke University's patents and regulatory filings related to umbilical cord blood and cord tissue. Cryo-Cell anticipates opening a clinic(s) to provide patients with greater access to cord blood treatments established by Duke University under the FDA granted Expanded Access Program.

CCEL hit almost $10 earlier this month. I think it looks attractive on this pullback to around $8. Any thoughts?